Acute Coronary Syndrome
Antiplatelet therapy has an essential role in treating acute coronary syndromes
Published in Medical Letter on the CDC and FDA, February 20th, 2005
According to the report from the United States, "The acute coronary syndromes (ACS), consisting of ST-segment elevation myocardial infarction (STEMI), non-STEMI (NSTEMI), and unstable angina, remain a leading cause of death in the United States. Through the process of atherothrombosis, underlying atherosclerosis can progress to an acute ischemic coronary event. This disease mechanism is also common to ischemic stroke and peripheral arterial disease."
J.J. Cavendish and colleagues of the U.S. Navy continued, "As ACS is a heterogeneous...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Antimicrobials
Findings advance knowledge in antimicrobials research - Bioterrorism Vaccine
Efficacy and safety of vaccines against bioterrorism evaluated - HIV/AIDS Pathogenesis
Mechanisms for macrophage-mediated HIV-1 induction investigated - Infection Control
Portable particulate air filtration for patient isolation evaluated - Lyme Disease
Immature ticks controlled on rodent reservoirs of B. burgdorferi - Mycobacteria
Mycobacterium cosmeticum isolated from cosmetic infections - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
